0.00Open0.03Pre Close0 Volume3.04K Open Interest77.00Strike Price0.00Turnover911.44%IV3.55%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type-0.0385Delta0.0434Gamma2660.00Leverage Ratio-30.1172Theta0.0000Rho-102.42Eff Leverage0.0002Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet